Phibro Animal Health Stock Price To Earnings To Growth
| PB8 Stock | EUR 20.80 0.20 0.97% |
Phibro Animal Health fundamentals help investors to digest information that contributes to Phibro Animal's financial success or failures. It also enables traders to predict the movement of Phibro Stock. The fundamental analysis module provides a way to measure Phibro Animal's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Phibro Animal stock.
Phibro |
Phibro Animal Health Company Price To Earnings To Growth Analysis
Phibro Animal's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Current Phibro Animal Price To Earnings To Growth | 1.79 X |
Most of Phibro Animal's fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Phibro Animal Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, Phibro Animal Health has a Price To Earnings To Growth of 1.7894 times. This is 152.03% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The price to earnings to growth for all Germany stocks is 63.41% higher than that of the company.
Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
Phibro Fundamentals
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0532 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 977.72 M | |||
| Shares Outstanding | 20.34 M | |||
| Shares Owned By Insiders | 0.54 % | |||
| Shares Owned By Institutions | 99.46 % | |||
| Price To Earning | 21.51 X | |||
| Price To Book | 2.32 X | |||
| Price To Sales | 0.52 X | |||
| Revenue | 942.26 M | |||
| Gross Profit | 285.72 M | |||
| EBITDA | 117.13 M | |||
| Net Income | 49.17 M | |||
| Cash And Equivalents | 93.21 M | |||
| Cash Per Share | 2.30 X | |||
| Total Debt | 417.93 M | |||
| Debt To Equity | 1.80 % | |||
| Current Ratio | 3.04 X | |||
| Book Value Per Share | 6.63 X | |||
| Cash Flow From Operations | 31.65 M | |||
| Earnings Per Share | 0.84 X | |||
| Price To Earnings To Growth | 1.79 X | |||
| Target Price | 20.0 | |||
| Number Of Employees | 1.86 K | |||
| Beta | 0.57 | |||
| Market Capitalization | 599.81 M | |||
| Total Asset | 931.7 M | |||
| Z Score | 1.6 | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 1.48 % | |||
| Net Asset | 931.7 M | |||
| Last Dividend Paid | 0.48 |
About Phibro Animal Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Phibro Animal Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Phibro Animal using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Phibro Animal Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Phibro Stock
When determining whether Phibro Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phibro Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phibro Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phibro Animal Health Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phibro Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.